SRPT logo

Sarepta Therapeutics (SRPT) Depreciation and amortization

annual D&A:

$37.72M-$6.67M(-15.03%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual depreciation & amortization is $37.72 million, with the most recent change of -$6.67 million (-15.03%) on December 31, 2024.
  • During the last 3 years, SRPT annual D&A has fallen by -$293.00 thousand (-0.77%).
  • SRPT annual D&A is now -15.03% below its all-time high of $44.40 million, reached on December 31, 2023.

Performance

SRPT Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

quarterly D&A:

$9.98M-$477.00K(-4.56%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly depreciation & amortization is $9.98 million, with the most recent change of -$477.00 thousand (-4.56%) on March 1, 2025.
  • Over the past year, SRPT quarterly D&A has increased by +$1.23 million (+14.11%).
  • SRPT quarterly D&A is now -12.26% below its all-time high of $11.37 million, reached on December 31, 2023.

Performance

SRPT quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

TTM D&A:

$38.96M+$1.23M(+3.27%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT TTM depreciation & amortization is $38.96 million, with the most recent change of +$1.23 million (+3.27%) on March 1, 2025.
  • Over the past year, SRPT TTM D&A has dropped by -$2.88 million (-6.88%).
  • SRPT TTM D&A is now -12.25% below its all-time high of $44.40 million, reached on December 31, 2023.

Performance

SRPT TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

SRPT Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-15.0%+14.1%-6.9%
3 y3 years-0.8%-6.9%-2.1%
5 y5 years+54.0%+52.8%+49.0%

SRPT Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-15.0%at low-12.3%+14.4%-12.3%+3.3%
5 y5-year-15.0%+54.0%-12.3%+54.1%-12.3%+49.0%
alltimeall time-15.0%>+9999.0%-12.3%+2429.7%-12.3%>+9999.0%

SRPT Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$9.98M(-4.6%)
$38.96M(+3.3%)
Dec 2024
$37.72M(-15.0%)
$10.46M(+6.6%)
$37.72M(-2.4%)
Sep 2024
-
$9.81M(+12.5%)
$38.64M(-2.8%)
Jun 2024
-
$8.72M(-0.3%)
$39.76M(-5.0%)
Mar 2024
-
$8.74M(-23.1%)
$41.84M(-5.8%)
Dec 2023
$44.40M(+6.1%)
$11.37M(+4.1%)
$44.40M(+1.9%)
Sep 2023
-
$10.93M(+1.3%)
$43.58M(+0.5%)
Jun 2023
-
$10.79M(-4.5%)
$43.35M(+2.1%)
Mar 2023
-
$11.30M(+7.1%)
$42.45M(+1.4%)
Dec 2022
$41.86M(+10.1%)
$10.55M(-1.4%)
$41.86M(+1.0%)
Sep 2022
-
$10.70M(+8.2%)
$41.46M(+0.5%)
Jun 2022
-
$9.89M(-7.7%)
$41.25M(+3.6%)
Mar 2022
-
$10.72M(+5.7%)
$39.81M(+4.7%)
Dec 2021
$38.02M(+41.3%)
$10.14M(-3.3%)
$38.02M(+8.1%)
Sep 2021
-
$10.49M(+24.2%)
$35.16M(+12.4%)
Jun 2021
-
$8.45M(-5.4%)
$31.28M(+6.7%)
Mar 2021
-
$8.93M(+22.5%)
$29.31M(+8.9%)
Dec 2020
$26.91M(+9.8%)
$7.29M(+10.1%)
$26.91M(+2.4%)
Sep 2020
-
$6.62M(+2.2%)
$26.27M(-0.5%)
Jun 2020
-
$6.47M(-0.8%)
$26.39M(+0.9%)
Mar 2020
-
$6.53M(-1.8%)
$26.15M(+6.7%)
Dec 2019
$24.50M(+100.1%)
$6.65M(-1.4%)
$24.50M(+14.6%)
Sep 2019
-
$6.74M(+8.1%)
$21.38M(+17.3%)
Jun 2019
-
$6.23M(+27.8%)
$18.23M(+22.6%)
Mar 2019
-
$4.88M(+38.3%)
$14.87M(+21.5%)
Dec 2018
$12.24M(+51.3%)
$3.53M(-1.8%)
$12.24M(+12.9%)
Sep 2018
-
$3.59M(+25.1%)
$10.84M(+10.5%)
Jun 2018
-
$2.87M(+27.6%)
$9.81M(+12.6%)
Mar 2018
-
$2.25M(+6.0%)
$8.71M(+7.6%)
Dec 2017
$8.09M(+44.2%)
$2.12M(-17.0%)
$8.09M(+6.0%)
Sep 2017
-
$2.56M(+44.4%)
$7.63M(+24.2%)
Jun 2017
-
$1.77M(+8.2%)
$6.15M(+5.1%)
Mar 2017
-
$1.64M(-1.6%)
$5.85M(+4.3%)
Dec 2016
$5.61M(+6.9%)
$1.66M(+54.9%)
$5.61M(+5.6%)
Sep 2016
-
$1.07M(-27.2%)
$5.31M(-4.3%)
Jun 2016
-
$1.48M(+5.7%)
$5.55M(+3.4%)
Mar 2016
-
$1.40M(+2.4%)
$5.36M(+2.2%)
Dec 2015
$5.25M(+42.2%)
$1.36M(+4.0%)
$5.25M(+4.1%)
Sep 2015
-
$1.31M(+1.6%)
$5.04M(+5.5%)
Jun 2015
-
$1.29M(+0.9%)
$4.78M(+7.4%)
Mar 2015
-
$1.28M(+10.5%)
$4.45M(+20.5%)
Dec 2014
$3.69M(+189.0%)
$1.16M(+10.4%)
$3.69M(+31.3%)
Sep 2014
-
$1.05M(+9.3%)
$2.81M(+37.2%)
Jun 2014
-
$960.00K(+83.6%)
$2.05M(+51.9%)
Mar 2014
-
$523.00K(+87.5%)
$1.35M(+5.6%)
Dec 2013
$1.28M(-16.3%)
$279.00K(-2.8%)
$1.28M(-10.9%)
Sep 2013
-
$287.00K(+10.4%)
$1.43M(-5.8%)
Jun 2013
-
$260.00K(-42.4%)
$1.52M(-6.3%)
Mar 2013
-
$451.00K(+3.7%)
$1.62M(+6.4%)
Dec 2012
$1.52M(+17.3%)
$435.00K(+16.0%)
$1.52M(-6.3%)
Sep 2012
-
$375.00K(+3.6%)
$1.63M(+6.7%)
Jun 2012
-
$362.00K(+2.5%)
$1.52M(+7.9%)
Mar 2012
-
$353.00K(-34.3%)
$1.41M(+8.8%)
Dec 2011
$1.30M(-11.1%)
$537.00K(+96.7%)
$1.30M(+10.8%)
Sep 2011
-
$273.00K(+8.8%)
$1.17M(-6.5%)
Jun 2011
-
$251.00K(+5.0%)
$1.25M(-7.4%)
Mar 2011
-
$239.00K(-41.7%)
$1.35M(-7.4%)
DateAnnualQuarterlyTTM
Dec 2010
$1.46M(+6.1%)
$410.00K(+15.5%)
$1.46M(+8.2%)
Sep 2010
-
$355.00K(+1.1%)
$1.35M(-0.1%)
Jun 2010
-
$351.00K(+1.2%)
$1.35M(-0.4%)
Mar 2010
-
$347.00K(+16.1%)
$1.36M(-1.5%)
Dec 2009
$1.38M(-6.1%)
$299.00K(-16.2%)
$1.38M(-8.4%)
Sep 2009
-
$357.00K(+0.3%)
$1.51M(+0.7%)
Jun 2009
-
$356.00K(-3.0%)
$1.50M(+0.5%)
Mar 2009
-
$367.00K(-13.8%)
$1.49M(+1.2%)
Dec 2008
$1.47M(-27.1%)
$425.60K(+22.9%)
$1.47M(-5.3%)
Sep 2008
-
$346.40K(-0.5%)
$1.55M(-11.0%)
Jun 2008
-
$348.00K(-0.3%)
$1.74M(-7.5%)
Mar 2008
-
$349.00K(-31.2%)
$1.88M(-6.5%)
Dec 2007
$2.01M(-3.7%)
$507.10K(-5.9%)
$2.01M(-1.1%)
Sep 2007
-
$538.70K(+10.3%)
$2.04M(+0.8%)
Jun 2007
-
$488.50K(+1.9%)
$2.02M(-1.2%)
Mar 2007
-
$479.60K(-9.5%)
$2.04M(-2.2%)
Dec 2006
$2.09M(+4.6%)
$529.70K(+1.3%)
$2.09M(-0.0%)
Sep 2006
-
$522.70K(+1.9%)
$2.09M(+1.5%)
Jun 2006
-
$512.80K(-2.3%)
$2.06M(+1.0%)
Mar 2006
-
$525.10K(-0.9%)
$2.04M(+2.1%)
Dec 2005
$2.00M(+5.8%)
$530.10K(+7.8%)
$2.00M(+0.6%)
Sep 2005
-
$491.90K(+0.1%)
$1.99M(-30.6%)
Jun 2005
-
$491.60K(+1.6%)
$2.86M(+47.3%)
Mar 2005
-
$484.00K(-6.7%)
$1.94M(+3.0%)
Dec 2004
$1.89M(+27.2%)
$518.60K(-62.1%)
$1.89M(+3.4%)
Sep 2004
-
$1.37M(-419.7%)
$1.83M(+126.5%)
Jun 2004
-
-$428.30K(-200.0%)
$805.90K(-49.0%)
Mar 2004
-
$428.30K(-6.1%)
$1.58M(+6.4%)
Dec 2003
$1.48M(+11.3%)
$456.20K(+30.5%)
$1.48M(+5.5%)
Sep 2003
-
$349.70K(+1.3%)
$1.41M(+0.1%)
Jun 2003
-
$345.30K(+3.6%)
$1.41M(+0.3%)
Mar 2003
-
$333.20K(-12.1%)
$1.40M(+5.0%)
Dec 2002
$1.33M(+139.6%)
$379.00K(+8.9%)
$1.33M(+12.0%)
Sep 2002
-
$347.90K(+2.2%)
$1.19M(+24.1%)
Jun 2002
-
$340.40K(+28.0%)
$959.90K(+31.6%)
Mar 2002
-
$266.00K(+12.5%)
$729.40K(+31.1%)
Dec 2001
$556.50K(+33.6%)
$236.50K(+102.1%)
$556.50K(+11.0%)
Sep 2001
-
$117.00K(+6.5%)
$501.30K(+6.5%)
Jun 2001
-
$109.90K(+18.0%)
$470.80K(+7.8%)
Mar 2001
-
$93.10K(-48.6%)
$436.90K(+4.9%)
Dec 2000
$416.50K(+38.8%)
$181.30K(+109.6%)
$416.50K(+24.3%)
Sep 2000
-
$86.50K(+13.8%)
$335.20K(-3.9%)
Jun 2000
-
$76.00K(+4.5%)
$348.70K(+27.9%)
Mar 2000
-
$72.70K(-27.3%)
$272.70K(-9.1%)
Dec 1999
$300.00K(+50.0%)
$100.00K(0.0%)
$300.00K(+50.0%)
Sep 1999
-
$100.00K(>+9900.0%)
$200.00K(0.0%)
Jun 1999
-
$0.00(-100.0%)
$200.00K(0.0%)
Mar 1999
-
$100.00K(>+9900.0%)
$200.00K(0.0%)
Dec 1998
$200.00K(-60.0%)
$0.00(-100.0%)
$200.00K(-50.0%)
Sep 1998
-
$100.00K(>+9900.0%)
$400.00K(+33.3%)
Jun 1998
-
$0.00(-100.0%)
$300.00K(-40.0%)
Mar 1998
-
$100.00K(-50.0%)
$500.00K(0.0%)
Dec 1997
$500.00K(0.0%)
$200.00K(>+9900.0%)
$500.00K(+66.7%)
Sep 1997
-
$0.00(-100.0%)
$300.00K(0.0%)
Jun 1997
-
$200.00K(+100.0%)
$300.00K(+200.0%)
Mar 1997
-
$100.00K
$100.00K
Dec 1996
$500.00K
-
-

FAQ

  • What is Sarepta Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual D&A year-on-year change?
  • What is Sarepta Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly D&A year-on-year change?
  • What is Sarepta Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Sarepta Therapeutics?
  • What is Sarepta Therapeutics TTM D&A year-on-year change?

What is Sarepta Therapeutics annual depreciation & amortization?

The current annual D&A of SRPT is $37.72M

What is the all time high annual D&A for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual depreciation & amortization is $44.40M

What is Sarepta Therapeutics annual D&A year-on-year change?

Over the past year, SRPT annual depreciation & amortization has changed by -$6.67M (-15.03%)

What is Sarepta Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of SRPT is $9.98M

What is the all time high quarterly D&A for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly depreciation & amortization is $11.37M

What is Sarepta Therapeutics quarterly D&A year-on-year change?

Over the past year, SRPT quarterly depreciation & amortization has changed by +$1.23M (+14.11%)

What is Sarepta Therapeutics TTM depreciation & amortization?

The current TTM D&A of SRPT is $38.96M

What is the all time high TTM D&A for Sarepta Therapeutics?

Sarepta Therapeutics all-time high TTM depreciation & amortization is $44.40M

What is Sarepta Therapeutics TTM D&A year-on-year change?

Over the past year, SRPT TTM depreciation & amortization has changed by -$2.88M (-6.88%)
On this page